SCHEMBL5599210

SCHEMBL5599210

CCc1ccc2cc(COc3c(F)c(F)c(F)c(F)c3F)ccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2A6 P11509 1/20 0.48
▸ POLB P06746 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KDM1A O60341 1/20 0.39
▸ AKR1C3 P42330 1/20 0.37
▸ AKR1C2 P52895 1/20 0.37
▸ NOS3 P29474 1/20 0.36
▸ NOS1 P29475 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ ALOX5 P09917 2/20 0.36
▸ F2 P00734 2/20 0.36
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36
▸ TUBB4B P68371 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5599385 0.88 CYP1A2 (0.41) CYP1A2CYP2A6KDM1ANOS3NOS1
SCHEMBL14866808 0.81 ALDH1A1 (0.38) POLBMAPTTDP1L3MBTL1AKR1C3
SCHEMBL21367618 0.75 MAPT (0.49) POLBMAPTTDP1L3MBTL1KDM1A
SCHEMBL29407167 0.74 CYP2A6 (0.80) CYP1A2CYP2A6MAPTL3MBTL1AKR1C3
SCHEMBL347592 0.74 CYP2A6 (0.80) CYP1A2CYP2A6MAPTL3MBTL1AKR1C3
SCHEMBL14016921 0.74 CYP1A2 (0.59) CYP1A2CYP2A6MAPTAKR1C3AKR1C2
SCHEMBL25847318 0.71 CYP1A2 (0.52) CYP1A2CYP2A6MAPTAKR1C3AKR1C2
SCHEMBL12017103 0.71 CYP1A2 (0.61) CYP1A2CYP2A6L3MBTL1AKR1C3AKR1C2
SCHEMBL14604945 0.71 CYP1A2 (0.61) CYP1A2CYP2A6MAPTL3MBTL1AKR1C3
SCHEMBL7729685 0.71 MAOB (0.39) POLBMAPTTDP1L3MBTL1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276633-B2 Method for production naphthalene derivatives MERCK PATENT GMBH (DE) 2007-10-02 — — US disclosed
US-20060025615-A1 Method for production naphthalene derivatives MERCK PATENT GMBH (DE) 2006-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025615-A1 Method for production naphthalene derivatives AOX1, AOC3, CBR3 CYP1A2 270/4885CYP2A6 646/4885POLB 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback